Insiders · IOBT

IOBT insider transactions

IO Biotech Inc. (IOBT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for IOBT

• 367d
  SEC Form 4 filed by Director Smith David V

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 367d
  SEC Form 4 filed by Director Hunter Heidi

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 367d
  SEC Form 4 filed by Director Hirth Peter

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 367d
  SEC Form 4 filed by Director Glaub Kathleen Sereda

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 367d
  SEC Form 4 filed by Director Elling Christian E

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 367d
  SEC Form 4 filed by Director Collins Helen Louise

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 371d
  Director Hunter Heidi bought $20,884 worth of shares (15,000 units at $1.39) (SEC Form 4)

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 430d
  SEC Form 4 filed by Chief Executive Officer Zocca Mai-Britt

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 430d
  SEC Form 4 filed by Chief Financial Officer Sullivan Amy

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 430d
  SEC Form 4 filed by General Counsel Smith Devin Whittemore

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 430d
  SEC Form 4 filed by Chief Accounting Officer Burkavage Brian

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 430d
  SEC Form 4 filed by Chief Medical Officer Ahmad Qasim Iftikhar

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 529d
  Chief Medical Officer Ahmad Qasim Iftikhar bought $26,553 worth of shares (31,350 units at $0.85) (SEC Form 4)

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 532d
  Chief Executive Officer Zocca Mai-Britt bought $10,120 worth of shares (12,500 units at $0.81), increasing direct ownership by 33% to 49,891 units (SEC Form 4)

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 532d
  Chief Financial Officer Sullivan Amy bought $8,483 worth of shares (10,250 units at $0.83), increasing direct ownership by 14% to 84,632 units (SEC Form 4)

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 532d
  General Counsel Smith Devin Whittemore bought $9,720 worth of shares (12,000 units at $0.81), increasing direct ownership by 243% to 16,938 units (SEC Form 4)

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 682d
  Large owner Novo Holdings A/S sold $99,125 worth of shares (75,000 units at $1.32), decreasing direct ownership by 2% to 4,354,449 units (SEC Form 4)

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 731d
  SEC Form 4 filed by Smith David V

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 731d
  SEC Form 4 filed by Hunter Heidi

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 731d
  SEC Form 4 filed by Hirth Peter

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 731d
  SEC Form 4 filed by Glaub Kathleen Sereda

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 731d
  SEC Form 4 filed by Elling Christian E

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 731d
  SEC Form 4 filed by Collins Helen Louise

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 755d
  Novo Holdings A/S sold $802,495 worth of shares (658,809 units at $1.22), decreasing direct ownership by 13% to 4,429,449 units (SEC Form 4)

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 812d
  SEC Form 4 filed by Zocca Mai-Britt

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 812d
  SEC Form 4 filed by Sullivan Amy

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 812d
  SEC Form 4 filed by Smith Devin Whittemore

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 812d
  SEC Form 4 filed by Burkavage Brian

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 812d
  SEC Form 4 filed by Ahmad Qasim Iftikhar

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 846d
  Novo Holdings A/S sold $988,411 worth of shares (658,809 units at $1.50), decreasing direct ownership by 11% to 5,088,258 units (SEC Form 4)

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 927d
  Burkavage Brian bought $10,125 worth of shares (10,000 units at $1.01), increasing direct ownership by 667% to 11,500 units (SEC Form 4)

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 934d
  SEC Form 4 filed by Collins Helen Louise

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 934d
  SEC Form 3 filed by new insider Collins Helen Louise

  3 - IO Biotech, Inc. (0001865494) (Issuer)
• 1022d
  SEC Form 3: New insider Kurma Partners claimed ownership of 6,821,133 shares

  3 - IO Biotech, Inc. (0001865494) (Issuer)
• 1028d
  SEC Form 4 filed by Hunter Heidi

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1028d
  SEC Form 3 filed by new insider Hunter Heidi

  3 - IO Biotech, Inc. (0001865494) (Issuer)
• 1032d
  SEC Form 4: Elling Christian E was granted 7,901,234 shares

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1032d
  SEC Form 4: Lundbeckfond Invest A/S was granted 7,901,234 shares, increasing direct ownership by 131% to 13,950,686 units

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1032d
  SEC Form 4: Novo Holdings A/S bought $4,999,998 worth of shares (2,469,135 units at $2.02), increasing direct ownership by 76% to 5,707,467 units

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1033d
  SEC Form 4: Vivo Capital Ix, Llc bought $5,999,999 worth of shares (3,157,894 units at $1.90)

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1034d
  SEC Form 4: Zocca Mai-Britt was granted 37,037 shares, increasing direct ownership by 10,462% to 37,391 units

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1034d
  SEC Form 4: Sullivan Amy was granted 49,382 shares, increasing direct ownership by 198% to 74,382 units

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1034d
  SEC Form 4: Smith Devin Whittemore was granted 4,938 shares

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1055d
  SEC Form 4 filed by Ahmad Qasim Iftikhar

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1055d
  SEC Form 3 filed by new insider Ahmad Qasim Iftikhar

  3 - IO Biotech, Inc. (0001865494) (Issuer)
• 1091d
  SEC Form 4 filed by Glaub Kathleen Sereda

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1091d
  SEC Form 4 filed by Smith David V

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1091d
  SEC Form 4 filed by Nielsen Jack

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1091d
  SEC Form 4 filed by Hirth Peter

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1091d
  SEC Form 4 filed by Elling Christian E

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1174d
  SEC Form 4 filed by Al-Hajj Muhammad

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1174d
  SEC Form 4 filed by Zocca Mai-Britt

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1174d
  SEC Form 4 filed by Sullivan Amy

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1174d
  SEC Form 4 filed by Burkavage Brian

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1174d
  SEC Form 4 filed by Ehrnrooth Eva

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1176d
  SEC Form 4 filed by IO Biotech Inc.

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1242d
  SEC Form 4 filed by Smith Devin Whittemore

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1242d
  SEC Form 3 filed by new insider Smith Devin Whittemore

  3 - IO Biotech, Inc. (0001865494) (Issuer)
• 1328d
  SEC Form 4 filed by Sullivan Amy

  4 - IO Biotech, Inc. (0001865494) (Issuer)
• 1328d
  SEC Form 3 filed by new insider Sullivan Amy

  3 - IO Biotech, Inc. (0001865494) (Issuer)